| A critical analysis of clinically available somatostatin analog formulations for therapy of acromegaly RD Murray, S Melmed The Journal of Clinical Endocrinology & Metabolism 93 (8), 2957-2968, 2008 | 269 | 2008 |
| Central and peripheral actions of somatostatin on the growth hormone–IGF-I axis RD Murray, K Kim, SG Ren, M Chelly, Y Umehara, S Melmed The Journal of clinical investigation 114 (3), 349-356, 2004 | 202 | 2004 |
| The diagnosis and management of inpatient hyponatraemia and SIADH P Grant, J Ayuk, PM Bouloux, M Cohen, I Cranston, RD Murray, A Rees, ... European Journal of Clinical Investigation 45 (8), 888-894, 2015 | 137 | 2015 |
| Influences on quality of life in GH deficient adults and their effect on response to treatment RD Murray, CJ Skillicorn, SJ Howell, CA Lissett, A Rahim, LE Smethurst, ... Clinical Endocrinology 51 (5), 565-573, 1999 | 125 | 1999 |
| The effect of long‐term untreated growth hormone deficiency (GHD) and 9 years of GH replacement on the quality of life (QoL) of GH‐deficient adults FJ Gilchrist, RD Murray, SM Shalet Clinical endocrinology 57 (3), 363-370, 2002 | 120 | 2002 |
| Adults with partial growth hormone deficiency have an adverse body composition RD Murray, JE Adams, SM Shalet The Journal of Clinical Endocrinology & Metabolism 89 (4), 1586-1591, 2004 | 119 | 2004 |
| GH-deficient survivors of childhood cancer: GH replacement during adult life RD Murray, KH Darzy, HK Gleeson, SM Shalet The Journal of Clinical Endocrinology & Metabolism 87 (1), 129-135, 2002 | 118 | 2002 |
| Dose titration and patient selection increases the efficacy of GH replacement in severely GH deficient adults. RD Murray, CJ Skillicorn, SJ Howell, CA Lissett, A Rahim, SM Shalet Clinical Endocrinology 50 (6), 749-757, 1999 | 109 | 1999 |
| Antigen-Specific Immunotherapy with Thyrotropin Receptor Peptides in Graves' Hyperthyroidism: A Phase I Study SHS Pearce, C Dayan, DC Wraith, K Barrell, N Olive, L Jansson, ... Thyroid, 2019 | 93 | 2019 |
| The novel somatostatin ligand (SOM230) regulates human and rat anterior pituitary hormone secretion RD Murray, K Kim, SG Ren, I Lewis, G Weckbecker, C Bruns, S Melmed The Journal of Clinical Endocrinology & Metabolism 89 (6), 3027-3032, 2004 | 92 | 2004 |
| Low bone mass is an infrequent feature of the adult growth hormone deficiency syndrome in middle-age adults and the elderly RD Murray, B Columb, JE Adams, SM Shalet The Journal of Clinical Endocrinology & Metabolism 89 (3), 1124-1130, 2004 | 78 | 2004 |
| Impact of growth hormone status on body composition and the skeleton A Mukherjee, RD Murray, SM Shalet Hormone Research in Paediatrics 62 (Suppl. 3), 35-41, 2004 | 75 | 2004 |
| Mortality data from the European Adrenal Insufficiency Registry—Patient characterization and associations M Quinkler, B Ekman, P Zhang, AM Isidori, RD Murray, ... Clinical endocrinology 89 (1), 30-35, 2018 | 74 | 2018 |
| Pituitary dysfunction following cranial radiotherapy for adult‐onset nonpituitary brain tumours N Kyriakakis, J Lynch, SM Orme, G Gerrard, P Hatfield, C Loughrey, ... Clinical endocrinology 84 (3), 372-379, 2016 | 69 | 2016 |
| A densitometric and morphometric analysis of the skeleton in adults with varying degrees of growth hormone deficiency RD Murray, JE Adams, SM Shalet The Journal of Clinical Endocrinology & Metabolism 91 (2), 432-438, 2006 | 69 | 2006 |
| Impaired quality of life in patients with treated acromegaly despite long‐term biochemically stable disease: Results from a 5‐years prospective study N Kyriakakis, J Lynch, SG Gilbey, SM Webb, RD Murray Clinical endocrinology 86 (6), 806-815, 2017 | 67 | 2017 |
| Low‐dose GH replacement improves the adverse lipid profile associated with the adult GH deficiency syndrome RD Murray, GE Wieringa, CA Lissett, KH Darzy, LE Smethurst, SM Shalet Clinical Endocrinology 56 (4), 525-532, 2002 | 67 | 2002 |
| Management of glucocorticoid replacement in adrenal insufficiency shows notable heterogeneity–data from the EU‐AIR RD Murray, B Ekman, S Uddin, C Marelli, M Quinkler, PMJ Zelissen, ... Clinical endocrinology 86 (3), 340-346, 2017 | 61 | 2017 |
| Prednisolone is associated with a worse lipid profile than hydrocortisone in patients with adrenal insufficiency M Quinkler, B Ekman, C Marelli, S Uddin, P Zelissen, RD Murray Endocrine connections 6 (1), 1-8, 2017 | 61 | 2017 |
| Growth hormone: current and future therapeutic applications RD Murray, SM Shalet Expert opinion on pharmacotherapy 1 (5), 975-990, 2000 | 54 | 2000 |
Ramzi AjjanUniversity of Leeds and Leeds Teaching Hospitals Trust
